|![[Search]](http://talks.cam.ac.uk/images/search.gif?1209136071)
|![[A-Z Index]](http://talks.cam.ac.uk/images/az.gif?1209136071)
|![[Contact]](http://talks.cam.ac.uk/images/contact.gif?1209136071)
||![[University of Cambridge]](http://talks.cam.ac.uk/images/identifier2.gif?1209136071){kind=small} |
COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. | ![[Talks.cam]](http://talks.cam.ac.uk/images/talkslogosmall.gif?1209136071) |
Cambridge Oncology Seminar Series
Add to your list(s)
Send you e-mail reminders
Further detail
This Seminar series covers clinical, laboratory and translational aspects of cancer. It is organised by members of the Cancer Research UK Cambridge Institute (CRUK CI), Clinical, Medical and Surgical Oncology and the Hutchison/MRC Research Centre. The programme is varied: in addition to external speakers, group leaders from each of the Departments give presentations. The talks are open to anyone from the University of Cambridge, Cancer Research UK and Addenbrooke’s Hospital. All talks take place on Tuesdays at 12 noon, unless otherwise indicated. The talks on the first Tuesday of the month are organised by the Hutchison/MRC Research Centre and take place in the Sackler Lecture Theatre, Level 7, CIMR . For information about this seminar series, please contact Anasuya Chattopadhyay (ac288@mrc-cu.cam.ac.uk) OR Judith Nial (jln23@mrc-cu.cam.ac.uk). The talks on the second, third and fourth Tuesdays of the month are held in the Cancer Research UK Cambridge Research Institute Lecture Theatre and the Sackler Lecture Theatre. These seminars are organised by Mala Jayasundera (mj319@cam.ac.uk). Members of the local pharma and biotechnology companies are also welcome to attend these seminars by prior arrangement with Neil Bennett (neil.bennett@cruk.cam.ac.uk). If you have a question about this list, please contact: Mala Jayasundera; Dr Ann Kaminski; Neil Bennett. If you have a question about a specific talk, click on that talk to find its organiser. 0 upcoming talks and 271 talks in the archive. CANCELLED - “Cancer genomics: from chromatin structure to new therapeutic targets”Host: Sakari Vanharanta
‘Cell Plasticity in Colon Carcinogenesis’Host: Grad Student Society -
‘Activation of transcription factor Nrf2 as a strategy to restore the cellular redox and protein homeostasis’Host: Christian Frezza (CF366@hutchison-mrc.cam.ac.uk)
‘Treatment of cancer by inhibition of mtDNA gene expression’Host: Christian Frezza - (Hutchison/MRC Research Centre Seminar)
‘Combining omics data and biological knowledge to understand and treat cancer’Host: Christian Frezza
‘Combining omics data and biological knowledge to understand and treat cancer’Host: Christian Frezza
‘Why Standard Naming and Pixel-based Contouring/Voluming are important to research in the radiation Oncology area’Host: Dr Richard Benson (richard.benson@addenbrookes.nhs.uk)
‘Next-Generation Biopsies in Gastrointestinal Cancers’Host: Dr Rebecca Fitzgerald (cf208@mrc-cu.cam.ac.uk)
‘New protagonists of the tumour microenvironment’Host: Sujath Abbas - sa837@mrc-cu.cam.ac.uk (Grad Student Society)
‘Mammary epithelial cell fate and tumour initiation at the single cell resolution’Host: Rebecca Fitzgerald
‘Multi-dimensional cancer-immune cell interaction during metastasis’Host: Sakari Vanharanta (SV358@MRC-CU.cam.ac.uk)
THIS SEMIAR IS NOW CANCELLED - 'Cell Plasticity in Colon Carcinogenesis'Host: Graduate Student Society (Sujath Abbas)
‘Executable Disease Networks: Reconstruction, Topology, Dynamics’Host: Ben Hall
‘Nuclear Mechanopathology & Early Cancer Diagnostics’Host: Ashok Venkitaraman ((Hutchison/MRC Research Centre Seminar) Contact:pa-venkitaraman@mrc-cu.cam.ac.uk
‘Cellular Plasticity in Cancer: driving force and therapeutic target’Host: Sakari Vanharanta (SV358@MRC-CU.cam.ac.uk) Hutchison/MRC Seminar
‘Accelerating the translation of mutational signatures'Host: Professor Ashok Venkitaraman (Hutchison/MRC Research Centre Seminar) Contact:pa-venkitaraman@mrc-cu.cam.ac.uk
"Proton Beam Therapy: Current and Future Provision"Host: Dr Gail Horan
‘Instituting Molecular Precision in Localised Prostate Cancer - A Cure for All?’Host: Professor Ashok Venkitaraman
Oxidative Stress Defences in CancerHost: Prof Ashok Venkitaraman (Queries to: AC288@MRC-CU.cam.ac.uk)
‘Tracking metabolic reprogramming in cancers with PI3K/Akt activation’Host: Christian Frezza
Metastasis latency: new molecular insightsHost: Sakari Vanharanta
‘The role of Mre11 in DNA double strand break repair - myth and facts’Host: Ashok Venkitaraman
Satellite RNAs, Heterochromatin and Cancer: A Novel Mechanism of Induction of Breast Cancer by Loss of BRCA1?Host: Professor Ashok Venkitaraman
‘Exploring and exploiting aberrant self-fate programs in leukemia’Host: Sakari Vanharanta (Hutchison/MRC talk)
'Analyses for Rule-Based Models of Cellular Signalling'SPECIAL COMPUTATIONAL BIOLOGY SEMINAR - Host by: Dr Ben Hall
‘Alterations of the Polycomb machinery in cancers’Host: Sakari Vanharanta (Hutchison/MRC talk)
‘Non-coding RNA - new roles for old players’Host: Dr Carla Martins
The interaction between tumor hypoxia and DNA methylationHost: Professor Ashok Venkitaraman
CANCELLED - Impact of the Microbiome on cancer and its treatmentHost: Dr Pippa Corrie
"Mechanisms of colon cancer initiation, progression and metastasis"Host: Sakari Vanharanta (Hutchison/MRC talk)
Mechanisms of lymphomagenesis: Developmental origins of a paediatric cancerHost Dr Simon Pacey
Computational Radiotherapy Symposium, 2016: personalised radiotherapy, or how computers can cure cancerOrganiser: Prof Neil Burnet (jms203@medschl.cam.ac.uk Tel: 01223768433)
Future of medicines development: capabilities and how industry is evolving and interacting with academia and the NHSHost: Dr Jean Abraham
“Mechanisms of MYC-driven genome instability”Host: Dr Anna Philpott
“Why Determining Pathogenicity in the Age of Precision Medicine, will Require More than Analyzing Genomic Sequences”Host: Dr Marc Tischkowitz
“New Developments in Molecular Imaging of Prostate Cancer”Host: Professor Fiona Gilbert
Innate Genetics and the Tumour Microenvironment Cooperate to Drive Prostate Cancer AggressionHost: Dr Simon Pacey
‘Combine and conquer: critical pre-clinical and clinical aspects of targeted anti-cancer drugs’Host: Dr Simon Pacey
"Tumor-induced reprogramming of hepatic metabolism disrupts anti‐tumor immunity”Host: Dr Simon Pacey
Intrinsic and extrinsic determinants of pancreatic cancer stem cellsHost: Hutchison/MRC Research Centre Graduate Student Society
Melanoma and the translational cycle of innovation in cancer therapeuticsHost: Dr Pippa Corrie
Genomics of radiation responses and radiosensitivityHost: Dr Ajithkumar
CANCELLED - "Synergistic effect of radiotherapy and cis-platinum chemotherapy delivered via gold nanoparticles in glioblastoma multiforme"CANCELLED
‘Novel dual-action combination therapy enhances angiogenesis whilst reducing tumour growth and spread’Hosts: Jacqui Shields/Sakari Vanharanta (Hutchison/MRC Research Centre)
Interrogating the Architecture of Cancer GenomesHost : Dr Bristi Basu
'Harnessing hypoxia signalling in cancer'Host: Dr Simon Pacey
'ECM remodelling during cancer progression'Hosts: Sakari Vanharanta and Jacqui Shields (Hutch)
DNA damage response: Mechanisms and relevance for cancer development and treatmentHutchison/MRC Research Centre Seminar - Host: Hutchison/MRC Research Centre Graduate Student Society
"Designing trials to find the right dose"Host: Dr Simon Pacey
Metastatic Stem Cells, TGF-beta signalling and poor-prognosis in CRCHutchison/MRC Research Centre Seminar
Defining treatment paradigms in prostate cancer; the UK as a dominant force - past, present, and futureHost: Dr Simon Pacey
Systems Biology of CancerHost: Hutchison/MRC Research Centre Graduate Student Society
MYC Oncoproteins act as Epigenetic ModifiersHutchison/MRC Research Centre Seminar - Host by: Dr Anna Philpott
“Optimizing Image Guided Radiotherapy for Patient Benefit”Host: Professor Neil Burnet
Explaining the reduction in ovarian cancer mortality 1977 to 2014Host: Dr Marc Tischkowitz
Ovarian Cancer in TransitionHost: Dr Christine Parkinson
In vivo function-based genomic approaches for cancer drug target discoveryHutchison/MRC Research Centre Seminar
Cell fate in response to anti-mitotic chemotherapeuticsHutchison/MRC Research Centre Seminar (please note unusual date)
Tracking genomic aberrations of the androgen receptor (AR) in castration-resistant prostate cancer (CRPC)Host: Dr Simon Pacey
“Stratified Medicine in Cancer Therapy - a practical guide”Host: Dr Nitzan Rosenfeld
"The role of epigenetic regulators and their therapeutic targeting in Acute Myeloid Leukaemia and haematological malignancies”Host: Professor Duncan Jodrell
CANCELLED - Lung cancer, biomarkers and unanswered questions - a clinical translational perspectiveHost: Dr Simon Pacey
The role of stem cells in the pathogenesis of hepato-biliary cancersHutchison/MRC Research Centre Seminar
“CDD’s new Research Strategy”Host: Professor Duncan Jodrell
“Paradigm changes produced by targeted agents in Phase I trials in Oncology. Case studies of a TFbeta inhibitor and a Sonic Hedgehog inhibitor”Host: Dr Richard Baird
Cellular hierarchies in normal and malignant epithelial tissueCRUK CI open seminar
'Scottish Collaboration On Translational Research into Renal Cell Cancer (SCOTRRCC): a springboard for renal cancer biomarker development’.Host: Professor Tim Eisen
Noninvasive cancer genomicsCRUK CI seminar
Precision Cancer Prevention: Trying to use Genomics to Save LivesHost: Dr Marc Tischkowitz
Breast Imaging research in CambridgeHost: Dr Richard Baird
Undermining Myc: Mitochondria Hold the KeyHutchison/MRC Research Centre Seminar
Personalised Cancer Medicine. How do we get there?Host: Dr Jean Abraham
"From trials evaluating drugs to trials evaluating treatment algorithms – Focus on the SHIVA trial"Host: Dr Gill Barnett
Spatio-temporal control of RhoGTPases and the cytoskeleton in invading cancer cells by integrins and endocytic traffickingHutchison/MRC Research Centre Seminar
Centrosome changes in cancer – causes and consequencesCRUK CI guest seminar
Targeting bioenergetics in hypoxic and rapidly growing tumoursHutchison/MRC Research Centre Seminar
“Personalized Medicine in Oncology: The Dutch experience”Host: Dr Richard Baird
Cell death and autophagy in response to inhibition of glycolysisHutchison/MRC Research Centre Seminar
“What can we do to accelerate the discovery of new medicines for patients?”Host: Dr Bristi Basu
Translating Tumour Metabolism into New Diagnostics and Novel Anti-Cancer TherapeuticsHutchison/MRC Research Centre Seminar
Personalized medicine initiative at Gustave RoussyHost: Dr Richard Baird
Chasing metabolic alterations in cancerHutchison/MRC Research Centre Seminar
CANCELLEDHost: Dr Richard Baird
The autophagy signaling network in the coordination of a cell's responseHutchison/MRC Research Centre Seminar
"The Cambridge Breast Cancer Programme"Host: Dr Richard Baird
MRC Cancer Unit Annual Lecture The p53 pathway: 21 years of the "guardian of the genome"Refreshments will be available after this talk outside the lecture theatre
CANCELLED - Scottish Collaboration On Translational Research into Renal Cell Cancer, developing a systems medicine approach to personalised treatment
Spotlight on Cambridge Clinical Trials; Presentations from the American Society of Oncology (ASCO) Annual Meeting 2013Host: Dr Simon Pacey
Target-Based Approach in Early-Phase Clinical Trials in CancerHost: Dr Richard Baird
CANCELLED
Advances in non-surgical treatment for cervix cancer
Insights for the role of tumour-related inflammation and stem cells in DrosophilaHutchison/MRC Research Centre Seminar
Risk and uncertainty in radiotherapy. Why I am the weakest link?
Genetic modifiers and microenvironmental control of tumor invasivenessHutchison/MRC Research Centre Seminar- Please note unusual time and 1:00pm start
"Image guidance – benefits and risks"
Economics of Cancer Medicines
Control of cytokinesis and the dark side of actomyosin forcesHutchison/MRC Research Centre Seminar
"Renal Cancer and Oxygen Sensing"
‘CLL – from chemotherapy to targeted kinase inhibition’Buffet Lunch will be provided by courtesy of Chugai Pharma UK Ltd.
Macrophages Into Tumor Hypoxic Areas: Should I Stay Or Should I Go?Hutchison/MRC Research Centre Seminar
“The identification of patients who benefit from targeted therapy in renal cancer”(The lunch will be provided by courtesy of Pfizer)
CANCELLED
Challenges in Implementing Personalized Cancer Medicine: the IGR experience
Telomeres and the challenges to chromosome integrityHutchison/MRC Research Centre Seminar
Localisation-based feedback controls during mitosis and the maintenance of chromosomal stabilityHutchison/MRC Research Centre Seminar
Cellular responses to DNA damage: translating molecular insights towards new cancer therapies
Mechanisms of Estrogen Receptor Transcription in Breast Cancer
"Towards personalized medicine in Breast Cancer"
A systems view of the cancer cell: from missing genetic variability to combination therapy
A genomic Odyssey of predicting drug response: is Ulysses home yet?
Signalling Networks in Cell Proliferation and Fate ControlHutchison/MRC Research Centre Seminar
'Circulating Tumour Cells: Biomarker Utility and Insights to Metastasis'
Understanding Response & Resistance Mechanisms to Targeted TherapyNote unusual day and time
Cancer-related inflammation
Pancreatic cancer: Genetic models to develop novel diagnostic and therapeutic strategies
"Strategies to enhance effectiveness of Radiotherapy in Pancreatic Cancer"
Investigating key effectors downstream of APC (adenomatous polyposis coli) deletion in vivoHutchison/MRC Research Centre Seminar
ALK Hunting in Colorado - new drugs for lung cancer's new diseasesNote unusual day and time
CANCELLED
Always on guard: p53 dynamics in single living cellsHutchison/MRC Research Centre Seminar
"Exploiting ASS1 deficiency in the treatment of mesothelioma"
"Thalidomide and its analogues ; How molecules selected for anti-TNFa activity affect so many different pathways with direct binding with Cereblon mediating both anti proliferative and Immunomodulatory functions"Individuals who are interested in meeting with any of the speakers should contact me asap. Thanks, Jonathan (jlh66@cam.ac.uk)
"Re Service Reforms in the new Commissioning Landscape"
"DICER1 and miRNA processing - a novel paradigm in cancer predisposition"
"Myeloproliferative neoplasms – JAK/STAT signalling and stem cell subversion"
"Radiotherapy toxicity, Radiogenomics and RAPPER"
Transcriptional control of EMT and malignant tumor progressionHutchison/MRC Research Centre Seminar
“Imaging Biomarkers in Cancer”
Neo-adjuvant radiochemotherapy in breast cancer
Integration of Cell Growth and Cell Metabolism by MycHutchison/MRC Research Centre Seminar
Cancer Gene Discovery in the MouseHutchison/MRC Research Centre Seminar
‘Genetic predisposition to cancer’
Tumour-stroma Interactions in Breast CancerHutchison/MRC Research Centre Seminar
DNA repair inhibitors in cancer treatment
Haploid Genetic Screens in Human CellsHutchison/MRC Research Centre Seminar
The ATM-mediated DNA damage response: moving between the forest and the treesHutchison/MRC Research Centre Seminar
‘Viral and host contributions to cervical carcinogenesis’
"Advances in Head and Neck Radiotherapy"
"Developing Medicines for Pancreatic Cancer"
SOCCAR trial: an update
“What lessons can we learn from transcriptional evolution in cancer research?”
CANCELLED
"Multi-site post-translational modification as a quantitative regulator of transcriptional output during neurogenesis"
CANCELLEDHutchison/MRC Research Centre Seminar
CANCELLED
"Somatic Genetics of Human Cancer - Moving Towards Large Scale Resequencing of Cancer Genomes"
"The Cambridge breast cancer program- recent progress"
"FGF-2, S6 Kinase 2 and Chemo-resistance in Lung Cancer"
Mesothelioma: a disease of our time
"Targetting pre-neoplasia in the bronchus"
Application of Systems Biology Approaches to Study Cell Signalling and TranscriptionHutchison/MRC Research Centre Seminar
"Leukaemia stem cells: how normal stem cell function is subverted in haematological malignancies"
“Breast MRI by the Shutter-Speed Method: Elimination of Unnecessary Breast Biopsies"
RCC Cinderella comes of age
Neuroblastoma- Disordered Developmental Programs Contribute to TumorigenesisHutchison/MRC Research Centre Seminar- Please note change to regular time and date
"Susceptibility to Cancer - What's New?"
Targeting NG2 Cells in Glioblastoma
"Chromosome Translocations and Tumour Suppressors in Breast Cancer"
"Brain Metastases – a cross cutting theme: Review of the Brain Metastasis Service and Future Research Potential"
"Imaging Tumour Cell Death"
“EGFR Mutation Screening in NSCLC”
Pathway Analysis of Glioblastoma Tissue After Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib – A Phase “0 Trial”
Interactions of Epidermal Growth Factor Receptor Inhibition with DNA damage in the treatment of gastrointestinal cancer
Unravelling cancer cell signalling networks and screening for novel drug targetsHutchison/MRC Research Centre Seminar
"Breast Radiotherapy - Past, Present and Future"
"Gastro Intestinal Stroma Tumours (GISTS)"
Dynamic Notch signaling in neural progenitor cellsHutchison/MRC Research Centre Seminar
"A New Window of Opportunity in Prostate Cancer"
"Stem cell identity and mRNA export: unexpected roles of geminin and GANP"
"Cellular Senescence as a Tumour Suppressor Mechanism, Particular Focus will be on the Autophagy/mTOR Pathway"
Mechanisms regulating neural differentiationHutchison/MRC Research Centre Seminar
“Macromolecular interactions in the control of chromosome instability”
The NCAG Report: Delivering a World Class Chemotherapy Service
"Non-Invasive Diagnosis of Brain Cancer"
Deciphering the Mammary Epithelial Cell Hierarchy
"The Fine Scale Mapping of Breast Cancer Loci found via GWAS - searching for the Causative Variants"
The Role of the Receptor Tyrosine Kinase Antagonist, Lrig1, in Normal Tissue Homeostasis and CancerHutchison/MRC Research Centre Seminar
CANCELLED
The prognostic significance of subtypes of breast cancer classified using immunohistochemistry
High-throughput Cancer Cell line Screens: Linking Drug Response to Molecular Signatures
Can we age in utero? Can we kill cancer cells by making them replicate faster? And other ATR stories…Hutchison/MRC Research Centre Seminar
HPV vaccines - will they do their job?
Investigating the interaction of Radiotherapy & Temozolomidefor Glioblastoma
PREDICT: A NEW UK PROGNOSTIC MODE THAT PREDICTS SURVIVAL FOLLOWING SURGERY FOR INVASIVE BREAST CANCER (GC Wishart, EM Azzato, PDP Pharoah, DC Greenberg, J Rashbass, O Kearins, G Lawrence, C Caldas C, PM Ravdin)
The new LAW of microRNA-mediated gene silencing: implications for lung cancer development
Cellular senescence: molecular mechanisms and implications for cancer and agingHutchison/MRC Research Centre Seminar
“Intensity modulated radiotherapy for children’s tumours and estimation of the carcinogenic risk”
"The Arguments for and against Sentinel Node Biopsy (SNB) in Melanoma"
The irreversibility of cell cycle transitions: why the clock never turns backHutchison/MRC Research Centre Seminar
Steroid Hormone Receptors in Prostate Cancer: A Hard Habit to Break?
"Phospholipase and lysophospholipase D signalling in cancer"
"Immunostimulatory antibodies in cancer treatment"
Molecular Mechanisms of Cellular Senescence in Cancer and AgeingHutchison/MRC Research Centre Seminar
Clinical Aspects of Proton Radiotherapy
Adoptive T Cell Therapy of Cancer
Genome scans in breast and prostate cancer - what have we learned & where next?
Germ Cell Tumours (GCTs) of Young People: Clinical and Biological Approaches
Is brain cancer a stem cell disease?
Translational imaging studies in ovarian cancer
A model for all genomes: the role of RNA polymerases fixed in factories
Using genetics to personalize melanoma therapy
Common germline variation and colorectal cancer
Taming the tiger by the tail: modulation of DNA damage responses by telomeres
OPCML in Tumour Gene Therapy in Ovarian Cancer
Preservation of fertility in patients with cancer
Connecting Lung Epithelial Stem Cells and Lung Cancer by Stress-Activated Protein Kinases
Analysis of early events after DNA damage in living cells; the HP1 paradigm
What comes after cancer stem cells?
Outreach chemotherapy programme
Radiation-induced bowel damage: let's put right what is wrong
The spatial organisation of Ras signaling
The role of cyclin-kinase inhibitors in the development of cancer
Clinical potential of functional ion channel expression in cancer
Role of the c-Myc-target gene Misu (NSun2) in regulating epidermal stem cell fate and its implications for cancer
Sarcomas and the insulin-like growth factor pathway
The evidence for lifestyle after cancer to reduce relapse and survival
Patterns of stem and progenitor cell fate in adult tissues
Title to be confirmedThis talk has now been postponed until next year
Delineating the Fanconi Anaemia DNA repair defect
The role of developmental biology in cancer research
Colorectal neoplasia: what we know and don't know about genes and environment
The Editorial Process DemystifiedNote unusual time and venue
The West Anglia CLRN, TCRNs and the Coordinated System for gaining NHS Permission – How is it all going to work?
The role of Fam38 in integrin activation and lung cancer
High-throughput cancer cell line screening: a tool for discovery
Title to be confirmed
Title to be confirmed
Early phase clinical trials in Cambridge
Special seminar: Analysing the dynamic glycomePlease note that this lecture is on a Wednesday at the CRI.
Chromatin modifying enzymes: their function and role in cancer
TBC
Using Bayesian analysis in randomised phase II clinical trials to determine the worth of proceeding to phase III
'Mechanisms of tamoxifen action and resistance' and 'Cambridge Oncology - Past, Present & Future: A tour from the 18th to 21st Century'
Taming Glioblastoma -Targeting Angiogenesis (CRI Special Seminar)
Trials and Tribulations in the Management of Head and Neck Cancer
TBC
TBC
Targeting Hyperactive Ras and Uncovering Mechanisms of Therapeutic Resistance in Genetically Engineered Mice
Chromosome translocations and gene fusions in breast cancer and Improving outcomes in melanoma: a fresh look
Title to be confirmed
Breast Cancer Heterogeneity and the Cancer Stem Cell Hypothesis
Title to be confirmed
'Monitoring anticancer drug uptake by magnetic imaging and spectroscopy' and 'Breast cancer heterogeneity- a clinical challenge'
Title to be confirmed
Experimental manipulation of the epidermis to study normal and cancer stem cells and The GIST of GISTS (Gastrointestinal Stromal tumours)
Title to be confirmed
Imaging biology in the cancer patient (K. Brindle)
"Computational biology and cancer: the CRI perspective" and "Lung Cancer: A New Strategy"
Acute Myeloid Leukaemia: Molecular Pathogenesis, Prognostication and Targeted therapy (Brian Huntly)
Beyond VEGF: vascular signaling targets for therapeutic manipulation
Searching for and confirming common breast cancer risk alleles (Dunning) Update on Diet and Breast Cancer (Bingham)
Progress in prostate cancer and the androgen receptor
Title to be confirmed
"High throughput mapping of cis-regulatory DNA elements: From genomic arrays to functional biology" (George Follows) & "Rapid evolutionary turnover of transcription factor binding" (Duncan Odom)
Gain-of-function JAK2 mutations in the human myeloproliferative disorders
Proteins that license DNA replication (Laskey) Clinical exploitation of proteins that license DNA replication (Coleman)
Title to be confirmed
Molecular genetics of MALT lymphoma: application in diagnosis and prognosis (Prof Ming Du), tbc (Prof Robert Marcus)
"Targeting the Met receptor for cancer therapy" (Ermanno Gherardi) and "Preclinical efforts in Pancreatic Cancer" (Dave Tuveson)
Targeting RET kinase activity as a novel therapeutic strategy for medullary thyroid carcinoma
Developments in radiotherapy: new treatments for today and tomorrow
Exploiting senescence and anoikis in function-based oncogenomic screensHost: Ashok Venkitaraman
Towards a fuller understanding of inherited susceptibility to colorectal cancer
Novel mechanisms of clinical drug resistance in ovarian cancer
Molecular heterogeneity of breast cancer - biological and clinical implications
Experimental cancer medicine at the Dana Farber Cancer Institute
Germline genetic predictors of prognosis in breast cancer
Dimethyl sulfoxide to vorinostat-targeted histone deacetylase inhibitor – mechanisms of action as an anti-cancer drug
RNAi Functional Analysis of Drug Resistance Pathways
Title to be confirmed
Please see above for contact details for this list. |
Other listsThin Film Magnetism Group Seminars Marshall Holiday Lectures Computer Laboratory Programming Research Group SeminarOther talksPaediatric malignancies: an overview The race to solve the solar metallicity problem with neutrinos and discover dark matter Challenges to monetary policy in a global context Surrogate models in Bayesian Inverse Problems Organoid systems to study the maternal-fetal dialogue of early pregnancy Computing High Resolution Health(care) From Euler to Poincare DataFlow SuperComputing for BigData The Digital Doctor: Hope, Hype, and Harm at the Dawn of Medicine’s Computer Age Graph Legendrians and SL2 local systems Physico-chemical biology in practice, 1920s–1930s |
Professor Elisa Oricchio (EPFL, Zurich).
Tuesday 07 April 2020, 11:30-12:30